Paasa Logo
Santen Pharmaceutical Co., Ltd. logo
4536JPXMarket closedOpens 9:00am JST

Santen Pharmaceutical Co., Ltd.

¥1,687.00Last updated
+¥22.50 (1.35%)Past day
Timezone

Santen Pharmaceutical Co., Ltd. (JPX: 4536) is trading at ¥1,687.00, about ₹1,030 at today's JPY/INR rate, as of 30 Sep 2026, 2:30 AM ET, up 1.35% today. Indian residents can buy Santen Pharmaceutical from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:¥1,665.00
Previous close:¥1,664.50
Volume:1.46M

Today's low

¥1,647.50

Today's high

¥1,694.00

52 week low

¥1,458.00

52 week high

¥2,254.00

4536 opened at ¥1,665.00, closed previously at ¥1,664.50, and has traded between ¥1,458.00 and ¥2,254.00 over the past 52 weeks.

About

Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addressing a variety of eye conditions. Its pipeline for glaucoma and ocular hypertension includes several key assets: DE-111, currently in Phase III clinical trials; DE-117, available for sale in Japan; DE-126, progressing through Phase IIb trials; DE-128, which is on the market in Europe and undergoing Phase II/III trials in the United States; and DE-130A, also in Phase III development. Beyond glaucoma, Santen's offerings extend to other ocular ailments. It provides DE-114A for allergic conjunctivitis and DE-076C for vernal keratoconjunctivitis. Furthermore, DE-109 is in Phase III clinical trials for the treatment of uveitis. The company is also active in addressing myopia with DE-127, currently in Phase II/III trials in Japan and Phase III in other Asian markets, alongside STN1013400, which is in Phase I trials. For dry eye, Santen offers DE-089C, which has successfully concluded its Phase III clinical trials. In addition to its prescription portfolio, the company produces and sells various over-the-counter (OTC) pharmaceutical products. Founded in 1890 under the name Santendo Pharmaceutical Co., Ltd., the company rebranded to its current name, Santen Pharmaceutical Co., Ltd., in 1958. It is headquartered in Osaka, Japan.

Country
JP
CEO
Takeshi Ito
Exchange listed on
JPX
Industry
Drug Manufacturers - General
Base currency
JPY
Full Time Employees
3,968
Sector
Healthcare
IPO date
04/01/2001

Key statistics

Avg. volume

1.23M

Market cap

¥542.69B

P/E Ratio

14.17

Price-to-sales ratio

1.86

Enterprise value

¥538.85B

Free cash flow yield

6.27%

Debt-to-equity ratio

0.10

Return on equity

12.58%

ROIC

10.57%

Beta

0.23

Dividend yield

2.37%

Last dividend

¥38.00

Financial overview

Revenue

¥291.62B

Earnings per share

¥114.04

Free cash flow

¥36.66B

Net profit margin

13.25%

Gross margin

56.10%

EBITDA

¥67.79B

Revenue growth

-2.79%

Similar securities

This is not an investment recommendation

How to buy Santen Pharmaceutical from India

Indian residents can buy Santen Pharmaceutical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.

  3. Search for Santen Pharmaceutical and place an order

    Find Santen Pharmaceutical by name or by its ticker, 4536, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Santen Pharmaceutical trades 5:30 am – 12:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Santen Pharmaceutical position in JPY and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Santen Pharmaceutical from India

Trading and taxes when buying Santen Pharmaceutical from India

Trading and limits

Trading hours
9:00 am – 3:30 pm JST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Santen Pharmaceutical’s current yield is 2.37%.Dividend tax explained
Estate or inheritance tax
May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Santen Pharmaceutical stock?

Yes. Santen Pharmaceutical (4536) has been listed on the Tokyo Stock Exchange since 2001, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Santen Pharmaceutical share cost in rupees?

One Santen Pharmaceutical share is ¥1,687.00 — about ₹1,030 at a JPY/INR rate of 0.6103 on 29 Sep 2026. Both the Santen Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Santen Pharmaceutical from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Santen Pharmaceutical?

The Tokyo Stock Exchange typically trades in units of 100 shares.

How are gains on Santen Pharmaceutical shares taxed in India?

Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Santen Pharmaceutical price. Paasa issues a capital-gains statement for your return.

Does Santen Pharmaceutical pay a dividend, and how is it taxed in India?

Yes. Santen Pharmaceutical pays a dividend and the current yield is 2.37%; the last declared dividend was ¥38.00 per share, about ₹23.19. Dividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Santen Pharmaceutical from India?

The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.

Is there estate or inheritance tax on Santen Pharmaceutical shares held from India?

Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.

Do I have to declare Santen Pharmaceutical shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Santen Pharmaceutical holding, its cost and its closing value.

How do I sell Santen Pharmaceutical and bring the money back to India?

You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.